Skip to main content
Log in

Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism?

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Serum thyroid hormones and antithyroid autoantibodies (AAB) were assayed in 87 randomly selected hypercholesterolemic persons compared to 80 controls with normal serum total cholesterol (TC). Of the 87 hypercholesterolemic persons 22 (25%) had positive AAB compared to 5 (6%) controls. Furthermore, 8 of the hypercholesterolemic patients had a serum TSH level above 5 mU/l, i.e. they had subclinical hypothyroidism, not diagnosed before, whereas thyroid function was normal in all normocholesterolemic persons. The new and unexpected finding was that the hypercholesterolemic persons had on average a significantly higher serum TSH than the controls, and this was true even when persons with positive AAB were excluded. There was a significant correlation between TC and serum TSH. It is concluded that hypothyroidism may not be an all-or-none phenomenon, and that many hypercholesterolemic persons with thyroid tests within the conventional normal range may have a slight impairment of their thyroid function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Goudie R.B., Anderson J.R., Gray K.G. Complement-fixing antithyroid antibodies in hospital patients with asymptomatic thyroid lesions. J. Path. Bact. 77: 389, 1959.

    Article  CAS  PubMed  Google Scholar 

  2. Buchanan W.W., Harden R.McG, Koutras D.A., Gray K.G. Abnormalities of iodine metabolism in patients with complement-fixing antimicrosomal thyroid autoantibodies, but no clinical evidence of thyroid disease: a subclinical form of Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 25: 301, 1965.

    Article  CAS  PubMed  Google Scholar 

  3. Bastenie P.A., Neve P., Bonnyns M., Vanhaelst L., Chaily M. Clinical and pathological significance of asymptomatic atrophic thyroiditis. A condition of latent hypothyroidism. Lancet 1: 915, 1967a.

    Article  CAS  PubMed  Google Scholar 

  4. Bastenie P.A., Vanhaelst L., Neve P. Coronary-artery disease in hypothyroidism. Observations in preclinical myxoedema. Lancet 2: 1221, 1967b.

    Article  CAS  PubMed  Google Scholar 

  5. Bastenie P.A., Vanhaelst L., Bonnyns M., Neve P. Preclinical hypothyroidism: a risk factor for coronary heart disease. Lancet 1: 203, 1971.

    Article  CAS  PubMed  Google Scholar 

  6. Bastenie P.A., Vanhaelst L., Gulstein I., Smets P.H. Asymptomatic autoimmune thyroiditis and coronary heart disease. Lancet 2: 155, 1977.

    Article  CAS  PubMed  Google Scholar 

  7. Bastenie P.A., Ermans A.M. Thyroiditis and thyroid function: Clinical, morphological and physiological studies. Pergamon Press, Oxford, New York, Toronto, Ruschcutters Bay, 1972.

    Google Scholar 

  8. Dean J.W., Fowler P.B.S. Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease. Br. Med. J. 290: 1555, 1985.

    Article  CAS  Google Scholar 

  9. Fowler P.B., Swale J., Andrews H. Hyper- cholesterolaemia in borderline hypothyroidism. Stage of premyxoedema. Lancet 11: 488, 1970.

    Article  Google Scholar 

  10. Salabe G.B., Salabe-Lotz H., Puletti M., Milani C. Hypothyroidism and thyroid autoimmunity in acute myocardial infarction (AMI). Thyroidology 1: 67, 1989.

    CAS  PubMed  Google Scholar 

  11. Heinonen O.P., Gordin A., Aho K., Punsar S., Pyoeraelae K., Puro K. Symptomless autoimmune thyroiditis in coronary heart disease. Lancet 1: 785, 1972.

    Article  CAS  PubMed  Google Scholar 

  12. Moulopoulos S.D., Adamopoulos P.N., Diamantopoulos E.I., Nanas S.N., Anthopoulos L.N., Iliadi-Alexandrou M. Coronary heart disease risk factors in a random sample of Athenian adults. Am. J. Epidemiol. 126: 882, 1987.

    CAS  PubMed  Google Scholar 

  13. Series J.J., Biggart E.M., O’Reilley D.S.T.J, Packard C.J., Shepherd J. Thyroid dysfunction and hypercholesterolemia in the general population of Glasgow, Scotland. Clin. Chem. Acta 172: 217, 1988.

    Article  CAS  Google Scholar 

  14. Calay R., Sohet L., Jonniaux G., Kocheleff P., Bastenie P.A. Dextrothyroxlne therapy for the disordered lipid metabolisms of preclinical hypothyroidism. Lancet 1: 205, 1971.

    Article  CAS  PubMed  Google Scholar 

  15. Althaus B.U., Staub J.-J., Ryff-De Leche A., Oberhansli A., Stahelin H.B. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin. Endocrinol. (Oxf.) 28: 157, 1988.

    Article  CAS  Google Scholar 

  16. Caron Ph., Calazel C., Parra H.J., Hoff M., Louvet J.P. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin. Endocrinol. (Oxf.). 33: 519, 1990.

    Article  CAS  PubMed  Google Scholar 

  17. Tieche M., Lupi G.A., Gutzwiller F., Grob P.J., Studer H., Burgi H. Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Br. Heart J. 46: 202, 1981.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pallas, D., Koutras, D.A., Adamopoulos, P. et al. Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism?. J Endocrinol Invest 14, 743–746 (1991). https://doi.org/10.1007/BF03347907

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347907

Key-words

Navigation